Vaxcyte Inc

NASDAQ:PCVX  
19.22
+0.13 (+0.68%)
Earnings Announcements

Vaxcyte Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Update

Published: 03/29/2021 21:11 GMT
Vaxcyte Inc (PCVX) - Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update.
Vaxcyte Inc - Qtrly Loss per Share $0.41.
Vaxcyte Inc - Cash and Cash Equivalents Were $386.2 Million As of Dec 31, 2020, Versus $59.0 Million As of Dec 31, 2019.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.